Stockreport

Agios Pharmaceuticals: Positive Phase 2 Results In Sickle Cell Study [Seeking Alpha]

Agios Pharmaceuticals, Inc.  (AGIO) 
Last agios pharmaceuticals, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.agios.com/investor-overview
PDF byakkayaAgios PharmaceuticalsNASDAQ:AGIOthe underlying causes of complex genetic disorders. With a strong commitment to patient-centered innovation, the company works on [Read more]